The results from NeoTract’s five year trial of the Prostatic Urethral Lift (PUL) have been published and show some very positive outcomes. Highlights of the study include:

• Durability of PUL:  Improvement in IPSS, QOL, BPHII, and Qmax were durable through 5 years

• Symptom Improvement:  IPSS improvement after PUL was 88% greater than that of sham at 3 months (*IPPS: International Prostate Symptom Score)

• Rapid Return to Activity:  LUTS and QOL were significantly improved by 2 weeks with return to preoperative physical activity within 8.6 days (*LUTS: Lower Urinary Tract Symptoms / QOL: Quality of Life)

• 0% Sexual Dysfunction:  Sexual function was stable over 5 years with no de novo, sustained erectile or ejaculatory dysfunction

Full details of the study along with statistics and references can be downloaded as a PDF from here.

UroLift® from NeoTract is a relatively new option for patients with an enlarged prostate looking for an alternative to drugs or major surgery. It is a minimally invasive approach to treating Benign Prostatic Hyperplasia (BPH) that lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. There’s no cutting, heating or removal of prostate tissue. For full details of  the UroLift procedure click here.